Quick Read

Former Governor Rick Perry and Bryan Hubbard detail how Texas secured $100 million for Ibogaine research, launching a multi-state movement to fast-track FDA approval for this psychedelic, which they claim offers unprecedented healing for addiction, trauma, and TBI, despite federal bureaucratic resistance.
Texas secured $100M to pursue FDA approval for Ibogaine, a psychedelic with high efficacy for addiction and TBI.
A multi-state coalition is forming to bypass federal bureaucracy, pushing for Ibogaine access through state legislation.
Ibogaine offers rapid, profound healing for opioid addiction, PTSD, and TBI, with personal testimonies and scientific backing.

Summary

Former Texas Governor Rick Perry and W. Bryan Hubbard return to the JRE to announce a groundbreaking $100 million Texas initiative to fund Ibogaine's FDA drug development process. They recount the intense five-and-a-half-month legislative campaign that secured overwhelming support from Texas lawmakers, culminating in Lieutenant Governor Dan Patrick's last-minute approval, heavily influenced by personal testimonies from veterans like Marcus Latrell. The discussion highlights Ibogaine's remarkable efficacy in treating opioid addiction (up to 98% success), PTSD, traumatic brain injury (TBI), and compulsive behaviors, citing Stanford research and Perry's own brain scan results showing neuro-regeneration. Hubbard and Perry detail the rapid expansion of their 'Americans for Ibogaine' movement, with multiple states (Mississippi, West Virginia, Kentucky, Oklahoma, Missouri, Louisiana) now advancing legislation to join Texas in a unified, state-led effort to overcome federal bureaucratic hurdles, particularly the DEA's Schedule I classification and restrictive interpretation of 'Right to Try' laws. They emphasize the spiritual dimension of psychedelic healing and call for presidential executive action to accelerate Ibogaine's integration into the U.S. healthcare system, framing it as a humanitarian mission to address national crises.
This episode reveals a significant, state-led challenge to federal drug policy, demonstrating how a powerful coalition of former politicians, veterans, and advocates is pushing for rapid medical innovation outside traditional federal channels. The Texas Ibogaine Initiative, backed by substantial funding and growing multi-state support, could set a precedent for psychedelic medicine development, potentially transforming treatment for addiction, PTSD, and TBI. It highlights the tension between bureaucratic inertia and urgent public health needs, offering a case study in grassroots and state-level political action driving a national paradigm shift in healthcare.

Takeaways

  • Texas has committed $100 million to fund the FDA drug development process for Ibogaine, a significant state-level investment in psychedelic medicine.
  • Ibogaine demonstrates remarkable efficacy in treating opioid addiction (85-98% success rate in 48-72 hours), PTSD, and traumatic brain injury (TBI), with evidence of neuro-regenerative properties.
  • A multi-state movement, 'Americans for Ibogaine,' is rapidly gaining traction, with states like Mississippi, West Virginia, and Kentucky passing or advancing legislation to join Texas in a unified drug development trial.
  • Federal bureaucracy, particularly the DEA's Schedule I classification and restrictive interpretation of 'Right to Try' laws, is identified as the primary obstacle to widespread Ibogaine access.
  • Former Governor Rick Perry's personal journey from skepticism to zealous advocacy, influenced by veterans and his own experience with concussions, highlights the shifting political landscape around psychedelics.
  • The movement emphasizes the spiritual and existential healing potential of Ibogaine, framing it as an 'emancipation movement for the mind, body, and soul' in response to a 'spiritual famine' in the U.S.

Insights

1Texas Secures $100 Million for Ibogaine Drug Development

The state of Texas has committed $100 million to fully fund the FDA drug development process for Ibogaine. This initiative, originally intended as a public-private partnership, was secured after a five-and-a-half-month legislative campaign that garnered 181 out of 188 legislative votes. Lieutenant Governor Dan Patrick's approval was critical, influenced by personal testimonies from veterans like Marcus Latrell.

W. Bryan Hubbard details the campaign from to , confirming the $100 million commitment from to . Rick Perry and Hubbard discuss Marcus Latrell's influence on Lt. Gov. Patrick from to .

2Ibogaine's Efficacy in Treating Addiction and Trauma

Ibogaine, an alkaloid from the Iboga shrub, has a unique capacity to interrupt physiological substance dependence (opioids, alcohol, meth, cocaine, tobacco) and compulsive behaviors (gambling, pornography). It can eliminate opioid addiction in 48-72 hours with an 85% success rate (up to 98% with two doses), without withdrawal symptoms. It also shows significant promise for treating PTSD and traumatic brain injury (TBI).

Hubbard describes Ibogaine's origin and addiction interruption effect from to . Perry states 85% of opioid addicts get clean in 72 hours at , and Rogan adds 98% with two doses at . Hubbard discusses TBI and neuro-regenerative capacities from to .

3Neuro-Regenerative Effects and Personal Testimony

Stanford University research on veterans with TBI indicates Ibogaine has 'remarkable neuro-regenerative capacities.' Former Governor Rick Perry, who had three severe concussions, underwent Ibogaine treatment and experienced a 27% increase in prefrontal cortex activity and the disappearance of brain atrophy, making his brain appear like that of a 40-year-old, according to his neurosurgeon.

Hubbard mentions Stanford research on TBI and neuro-regenerative capacities from to . Perry details his personal experience with concussions, anxiety, insomnia, and the results of his brain scans (27% increase in prefrontal cortex, atrophy gone, brain like a 40-year-old) from to .

4Multi-State Movement to Bypass Federal Bureaucracy

The 'Americans for Ibogaine' organization is catalyzing a multi-state movement to force federal action. After Texas's success, 22 states were engaged, leading to legislative efforts in Mississippi, West Virginia, Kentucky, Oklahoma, Missouri, and Louisiana to join Texas in a unified FDA drug development trial. The American Legislative Exchange Council (ALEC) has also endorsed this initiative, issuing model legislation.

Perry discusses the growth of Americans for Ibogaine and ambassadors from to . Hubbard details the Aspen summit (22 states) and ALEC endorsement from to , then lists specific states advancing legislation from to .

5Federal Obstacles: DEA's Schedule I Classification and 'Right to Try' Interpretation

Ibogaine's Schedule I classification by the DEA (no medical purpose, highly addictive) is a major impediment, despite evidence to the contrary. The DEA also restricts access under the federal 'Right to Try' law, asserting it does not apply to Schedule I substances, directly contradicting the bill's author, Senator Kyrsten Sinema, who stated the law applies to 'any medication' that clears Phase 1 safety testing.

Perry discusses Nixon's war on drugs and Schedule I classification from to . Hubbard explains the DEA's interpretation of 'Right to Try' and its conflict with Senator Sinema's intent from to .

6Spiritual and Existential Healing Potential

Beyond physical healing, Ibogaine and other psychedelics are framed as tools for spiritual reawakening, revealing 'individual human divinity' and helping individuals find purpose and overcome 'spiritual famine.' This spiritual dimension is seen as crucial for societal cohesion, especially in an era of technological advancement like AI, to prevent a 'Mad Max' future and usher in an 'age of unlimited abundance.'

Hubbard discusses Ibogaine confirming 'individual human divinity' from to . He elaborates on the 'spiritual famine' and 'emancipation movement' from to , and the need for spiritual reawakening to navigate the age of AI and abundance from to .

Bottom Line

Ibogaine shows preliminary, 'otherworldly' potential for treating neurodegenerative diseases like Parkinson's, Multiple Sclerosis, and Lyme disease, as well as post-surgical complications related to brain tumors, though more research is needed to understand its specific efficacy and limitations.

So What?

If validated, this could open entirely new avenues for treating currently incurable or debilitating conditions, extending Ibogaine's impact far beyond addiction and trauma into broader neurological health.

Impact

Further research funding and clinical trials specifically targeting neurodegenerative diseases and other complex conditions could unlock massive therapeutic potential, attracting significant investment and scientific interest.

The Iboga shrub, native to Gabon, grows in pairs where one is the 'real deal' and the other is a 'poison impostor,' visually identical until maturation (10 years) when only the real one bears fruit. Traditional Pygmy communities can differentiate them by taste even when mixed.

So What?

This biological phenomenon highlights the complexity of natural medicine sourcing and the critical role of indigenous knowledge, while also posing challenges for scalable, safe cultivation and preventing adulteration in illicit markets.

Impact

Developing advanced botanical identification and quality control methods, potentially leveraging traditional knowledge, is crucial for establishing a reliable and safe supply chain for Ibogaine, especially as global demand increases.

The current political and social climate, marked by a 'spiritual famine' and widespread loneliness, makes society particularly receptive to the profound, identity-affirming experiences offered by psychedelics, positioning them as catalysts for a necessary societal 'reawakening.'

So What?

This suggests that the movement for psychedelic medicine is not just about healthcare but also addresses deeper societal needs for meaning, connection, and purpose, potentially accelerating its adoption beyond purely medical applications.

Impact

Framing psychedelic access within a broader narrative of societal well-being and spiritual growth could resonate with a wider audience, fostering greater public and political support for reform.

Opportunities

State-Sponsored Ibogaine Drug Development & Research Centers

Establish and fund state-level centers, like the Texas Ibogaine Initiative, to conduct FDA-compliant clinical trials for Ibogaine. These centers would collaborate across states to accelerate the approval process and gather comprehensive data on efficacy for various conditions (addiction, TBI, PTSD, neurodegenerative diseases).

Source: W. Bryan Hubbard, Rick Perry

Specialized Ibogaine Treatment Facilities (Post-Phase 1 'Right to Try')

Develop and operate specialized clinics, potentially on sovereign tribal lands or in states with favorable 'Right to Try' laws, that can offer Ibogaine treatment to individuals with life-threatening conditions once it clears FDA Phase 1 safety testing. This would cater to immediate demand while full FDA approval is pending.

Source: W. Bryan Hubbard

Ibogaine Supply Chain and Cultivation Development

Partner with countries like Gabon, the native source of Iboga, to develop sustainable and ethical cultivation practices. This includes research into different Iboga varietals, optimal growing conditions, and methods to differentiate the active plant from its 'poison impostor' to ensure a safe and consistent supply of Ibogaine.

Source: W. Bryan Hubbard

Key Concepts

Curiosity vs. Dogma

The guests, particularly Rick Perry, emphasize the importance of open-mindedness and curiosity over rigid adherence to dogma, citing their own shifts in perspective on criminal justice reform and psychedelics. This model highlights how a willingness to question established beliefs and engage with new information can lead to significant personal and societal change.

State-Led Federal Pressure

This model describes the strategy of building a coalition of states to collectively push for federal policy change when direct federal action is stalled by bureaucracy or political resistance. By undertaking drug development and legislative efforts at the state level, the movement aims to create an 'unstoppable external force' that compels the federal government to respond and integrate new medical breakthroughs.

Bureaucratic Inertia

The concept that government agencies, like the DEA, tend to resist change and default to 'no' due to a preference for safety, established procedures, and arbitrary interpretations of law, even when faced with compelling evidence or legislative intent. This inertia is presented as a major impediment to rapid innovation and public health solutions.

Lessons

  • Contact your state legislators (especially in Missouri and Kentucky) to advocate for the passage of Ibogaine initiatives, urging them to join the multi-state effort to accelerate drug development and access.
  • Support organizations like 'Americans for Ibogaine' (AmericansforIbogaine.org) through donations or by becoming an ambassador, contributing to the public policy and advocacy efforts to integrate Ibogaine into the U.S. medical system.
  • Engage in conversations about psychedelic medicine with an open mind, challenging outdated stereotypes and educating others on the scientific evidence and personal testimonies regarding compounds like Ibogaine, fostering a culture of curiosity over dogma.

Notable Moments

Rick Perry's personal transformation from 'tough on crime' to psychedelic advocate, influenced by Marcus Latrell's near-suicide and his own concussions, risking his reputation for the cause.

This demonstrates the powerful impact of personal experience and scientific evidence in shifting deeply held political and ideological beliefs, highlighting the potential for unexpected champions in drug policy reform.

W. Bryan Hubbard's impassioned critique of Kentucky Governor Andy Beshear and his father for their alleged role in malpracticing a lawsuit against Purdue Pharma, resulting in a minimal settlement for the people of Kentucky affected by the opioid crisis.

This moment exposes deep-seated corruption and conflicts of interest within the political and legal systems, illustrating how powerful entities can obstruct justice and perpetuate public health crises for financial gain, directly contrasting with the humanitarian goals of the Ibogaine movement.

The story of Tamara, a child sexual abuse survivor who became addicted to opioids prescribed for reconstructive surgeries, ending up in jail, illustrating the systemic failures in addressing trauma and addiction.

This narrative powerfully humanizes the opioid crisis, demonstrating how initial medical interventions can inadvertently lead to addiction and incarceration, underscoring the urgent need for effective, holistic treatments like Ibogaine.

Quotes

"

"Ibagain confirms without question the reality of our individual human divinity. And that is the greatest truth conveyed by this fabulous plant."

W. Bryan Hubbard
"

"You are not your ideas. You are not your opinions. These are just thoughts and if you identify with them, you are trapped in them and you will be held hostage by them."

Joe Rogan
"

"The most morally depraved criminal in America today, is power. And the power of the human hand when it is wielded in its most abusive context will always seek to deny any access to individual human divinity and the liberty and autonomy that is conferred upon each of us as children of God."

W. Bryan Hubbard
"

"How bad you got to hate people to not make that available?"

Rick Perry

Q&A

Recent Questions

Related Episodes